Showing results (41-50 of 356) with videos related to

Sort By:
Pageof 36
European Journal of Immunology|April 23, 2010
Modulating numbers and phenotype of CD8+ T cells in secondary immune responsesThomas C Wirth, John T Harty, Vladimir P Badovinac
Der Pathologe|July 14, 2021
BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic optionsMichael Hummel, Susanna Hegewisch-Becker, Jens H L Neumann, et al.
Cancer Treatment Reviews|January 1, 2023
Chemosaturation for primary and secondary liver malignancies: A comprehensive update of current evidenceArndt Vogel, Sebastian Ochsenreither, Jonathan S Zager, et al.
Oncology Research and Treatment|April 30, 2018
Biliary Tract Cancer: Implicated Immune-Mediated Pathways and Their Associated Potential TargetsNoor-Ul-Ain Tariq, Arndt Vogel, Mairead G McNamara, et al.
World Journal of Gastroenterology|May 31, 2024
Hepatocellular carcinoma-the role of the underlying liver disease in clinical practiceAngelo Zambam de Mattos, Isadora Zanotelli Bombassaro, Arndt Vogel, et al.
Therapeutic Advances in Medical Oncology|August 11, 2021
Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumabChiun Hsu, Lorenza Rimassa, Hui-Chuan Sun, et al.
Journal of Hepatology|December 17, 2022
Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinomaGajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, et al.
Plos One|May 7, 2019
LINE-1 hypomethylation in human hepatocellular carcinomas correlates with shorter overall survival and CIMP phenotypeSumadi Lukman Anwar, Britta Hasemeier, Elisa Schipper, et al.
Cancer Treatment Reviews|August 29, 2022
Cabozantinib after prior checkpoint inhibitor therapy in patients with solid tumors: A systematic literature reviewJeffrey Graham, Arndt Vogel, Ann-Lii Cheng, et al.
Pageof 36